Alexithymia was first described by Sifneos [1] as difficulty identifying and communicating
feelings, differentiating feelings and somatic sensations of emotional arousal, a diminution
of fantasy and imagination and an externally oriented cognitive style [2]. Studies have found
that alexithymia is present across 18 different ethnic and racial groups [3]. Alexithymia is
seen in around 6 and 10% in the general population [4-5]. However, when compared to
non-addicted individuals, those with substance-use disorders more frequently exhibit
alexithymia [6]. In patients with alcohol-use disorders percentages typically range from 45
to 67% [7]. Alexithymia can also be seen in people with a family history of alcoholism [8].
Some evidence suggests that alexithymia may have an adverse impact on the treatment of
alcohol use disorders [9,10] and given the substantial cost of such disorders worldwide [11]
this relationship warrants closer attention. Alexithymia is also commonly found in patients
who are undergoing treatment for another drug abuse [12].
Substance-use disorders are linked with affective disorders, and alexithymia is seen in
association with depressive [13,14] and anxiety disorders [15]. Thus, alexithymia may be seen
in substance-use disorders simply because alexithymia is commonly observed in affective
disorders that often accompany substance-use disorders. Thus, such individuals may seek to
relieve depression or anxiety brought about by alexithymia by consuming alcohol or other drugs
[16]. However, alexithymia may represent a separate entity, [17] consistent with observations
that not all individuals with co-occurring alexithymia and substance dependence exhibit
affective disorders [18]. Reports on alexithymia have shown a link between alexithymia and
a chronically elevated stress response [19], perhaps because an inability to identify negative
emotion makes such emotions harder to regulate. Alexi thymic individuals demonstrated more
displacement behaviors, such as self-grooming and scratching, which may denote a failure to
regulate distress [20]. Imaging studies using fMRI indicate that subjects with alexithymia have
reduced activation of the temporoparietal junction and dorsomedial prefrontal cortex in the
brain. These areas are related to mentalizing ability. These findings indicate that alexithymia
is associated with an impairment in mentalizing ability resulting in an inability to understand
the perspective of others [21]. Individuals with alexithymia also showed decreased executive
function capabilities, with reductions in performance across multiple domains of executive
function, including inhibition [22]. Since people with alexithymia usually feel uncomfortable
in social situations [23], some studies have proposed that alexithymia individuals use alcohol
as a coping mechanism for stress or to improve interpersonal functioning [24,25]. Studies
suggest association between alexithymia and craving for drugs or alcohol, although the
directionality has not been seen consistently. Negative correlations between alexithymia
and subjective measures of craving for alcohol in response to alcohol cues have been found
among patients with alcohol dependence [26], whereas positive correlations between
alexithymia and cue-induced craving for methamphetamine have been seen in patients with
methamphetamine dependence [27]. High alexithymia in heavy alcohol users is associated
with increased craving for alcohol, compulsive urge to drink, and obsessive thoughts about
alcohol [28].
De Haan et al. [29] in a study on inpatients with alcohol use disorder and found that
the baseline alexithymia showed no relation to abstinence, time in treatment or changes in
disorder severity at 1-year follow-up [29]. In another study de Haan et al. [29] showed that
alexithymia was not related to abstinence, and high scoring alexithymics did not differ from
low-scoring alexithymics in mean time in treatment or dropout
rates (50 vs. 43%) [29]. It can also predict treatment engagement
especially session attendance and working alliance, as it was
found by Cleland et al. [30] That drug-dependent outpatients who
were higher in alexithymia attended fewer sessions and formed
weaker alliances [31]. A prospective study on subjects with alcohol
dependence by Junghanns et al. [32] in 2005 found that alexithymia
scores were not associated with the risk of relapse at 6-week
follow-up [32]. A recent research confirmed that alexithymia was
not associated with treatment adherence or retention in an 8-week
randomized clinical trial by Morie et al. [18] in 2015 [18]. Thus,
evidence on the relationship between alexithymia and treatment
outcome is limited and non-univocal. Substance use treatment
is hindered by high rates of relapse (60–70%) and premature
termination, to the extent that it is more common for a patient to
drop out of addiction treatment than to complete the treatment
[32-35]. According to Hser et al. [34] completion of addiction
treatment is one of the most consistent factors associated with a
favorable treatment outcome [34,36]. This shows the importance
of identifying predictors of treatment retention and adherence in
such patients. Thus, there is evidence that alexithymia plays a role
in development of alcohol use disorders and has the potential to
interfere with its treatment. Unfortunately, it is neither assessed
nor addressed in routine management of addictive disorders. Welldesigned
studies are needed to establish the role of alexithymia in
management and whether management of alexithymia can play a
role in the treatment of substance use disorders.
Nemiah JC, Freyberger H, Sifneos PE (1976) Alexithymia: A view of the psychosomatic process. In: Hill O (Ed.), Modern trends in psychosomatic medicine, Butterworths, London, UK.
Onur E, Alkin T, Sheridan MJ, Wise TN (2013) Alexithymia and emotional intelligence in patients with panic disorder, generalized anxiety disorder and major depressive disorder. Psychiatry Q 84(3): 303-311.
Professor, Chief Doctor, Director of Department of Pediatric Surgery, Associate Director of Department of Surgery, Doctoral Supervisor Tongji hospital, Tongji medical college, Huazhong University of Science and Technology
Senior Research Engineer and Professor, Center for Refining and Petrochemicals, Research Institute, King Fahd University of Petroleum and Minerals (KFUPM), Dhahran, Saudi Arabia
Interim Dean, College of Education and Health Sciences, Director of Biomechanics Laboratory, Sport Science Innovation Program, Bridgewater State University